Back
Bruker Corp. 10K Form
Sell
29
BRKR
Bruker Corp.
Last Price:
$48.39
Seasonality Move:
5.87%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-10 | 10Q | BRKR/Bruker Corp. Quarterly |
| 2024-02-29 | 10K | BRKR/Bruker Corp. Annual |
| 2023-11-09 | 10Q | BRKR/Bruker Corp. Quarterly |
| 2023-08-09 | 10Q | BRKR/Bruker Corp. Quarterly |
| 2023-05-10 | 10Q | BRKR/Bruker Corp. Quarterly |
| 2023-03-01 | 10K | BRKR/Bruker Corp. Annual |
Receive BRKR News And Ratings
See the #1 stock for the next 7 days that we like better than BRKR
BRKR Financial Statistics
Sales & Book Value
| Annual Sales: | $3.4B |
|---|---|
| Cash Flow: | $-54.1M |
| Price / Cash Flow: | 124.42 |
| Annual Sales: | $16.06 |
| Price / Book: | 2.99 |
Profitability
| EPS (TTM): | -0.15630 |
|---|---|
| Net Income (TTM): | $-23.6M |
| Gross Margin: | $1.7B |
| Return on Equity: | -1.2% |
| Return on Assets: | -0.39% |
Bruker Corp. Earnings Forecast
Key Bruker Corp. Financial Ratios
-
The Gross Profit Margin over the past 26 years for BRKR is 49.34%.
-
The Selling, General & Administrative Expenses for BRKR have been equal to 26.55% of Gross Profit Margin.
-
The Research & Development expenses have been 11.18% of Revenue.
-
The Interest Expense is 42.09% of Operating Income.
-
The Net Earning history of BRKR is 3.38% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 15 years.
Bruker Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | BRKR |
| CUSIP: | 116794 |
| Website: | bruker.com |
Debt
| Debt-to-Equity Ratio: | 0.83 |
|---|---|
| Current Ratio: | 1.85 |
| Quick Ratio: | 0.76 |
Price-to-Earnings
| Trailing P/E Ratio: | 63.27 |
|---|---|
| Forward P/E Ratio: | 22.24 |
BRKR Technical Analysis vs Fundamental Analysis
Sell
29
Bruker Corp. (BRKR)
is a Sell
Is Bruker Corp. a Buy or a Sell?
-
Bruker Corp. stock is rated a SellThe current Bruker Corp. [BRKR] share price is $47.86. The Score for BRKR is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.